Y-mAbs Therapeutics, Inc. ( YMAB) - Key Metrics
Stock symbol YMAB is outdated, potentially delisted? Maybe it is available on other exchange?
YMAB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q2 | $0.43 | -$0.07 | $0.04 | $0.04 |
| 2025Q1 | $0.46 | -$0.12 | -$0.15 | -$0.16 |
| 2024Q4 | $0.59 | -$0.15 | -$0.04 | -$0.04 |
| 2024Q3 | $0.41 | -$0.16 | -$0.24 | -$0.24 |
| 2024Q2 | $0.52 | -$0.21 | $0.01 | $0.01 |
YMAB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q2 | ? | -15.78 |
| 2025Q1 | ? | -9.61 |
| 2024Q4 | ? | -12.94 |
| 2024Q3 | ? | -20.96 |
| 2024Q2 | ? | -14.08 |
YMAB Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q2 | 0.81% | ? |
| 2025Q1 | -3.52% | ? |
| 2024Q4 | -0.53% | ? |
| 2024Q3 | -1.82% | ? |
| 2024Q2 | 0.06% | ? |
YMAB
Price: $8.61
52 week price:
Earnings Per Share: -0.50 USD
P/E Ratio: -17.14
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 294900
Market Capitalization: 389.4 million